Clinical Trial Update: Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s) [Phase 3]

View source ↗

Summary

This report notes a Phase 3 trial evaluating insulin glargine in insulin-naive adults with type 2 diabetes who are taking oral glucose-lowering agents; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED